ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2020
Keeping standards of multiple sclerosis care through the COVID-19 pandemic.
Article in Multiple sclerosis (Houndmills, Basingstoke, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- MS treatment trends before, during, and after the COVID-19 pandemic: insights from the German MS Register.Journal of neurology · 2025Article
- COVID-19 and multiple sclerosis: challenges and lessons for patient care.The Lancet regional health. Europe · 2024Review
- The quality of life impact of the COVID-19 pandemic and lockdowns for people living with multiple sclerosis (MS): evidence from the Australian MS Longitudinal Study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024Article
- Serology results after COVID vaccine in multiple sclerosis patients treated with fingolimod.Revue neurologique · 2023Article
- An expert patient program to improve the empowerment and quality of life of people with multiple sclerosis: protocol for a multicenter pre-post intervention study.Frontiers in neurology · 2023Article
- Exploring the impact of the COVID-19 pandemic on social isolation and mental health in people with MS.Multiple sclerosis and related disorders · 2022Article
- Physiotherapy for Multiple Sclerosis Patients From Early to Transition Phase: A Scoping Review.Cureus · 2022Article
- Disaster and Multiple Sclerosis: A Systematic Review.Iranian journal of public health · 2022Review
- Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre.Journal of neurology · 2022Article
- Innovating Care in Multiple Sclerosis: Feasibility of Synchronous Internet-Based Teleconsultation for Longitudinal Clinical Monitoring.Journal of personalized medicine · 2022Article
- Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey.Multiple sclerosis (Houndmills, Basingstoke, England) · 2022Article
- The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic.Biomolecules · 2021Review
- The effect of the Australian bushfires and the COVID-19 pandemic on health behaviours in people with multiple sclerosis.Multiple sclerosis and related disorders · 2021Article
- Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance.Multiple sclerosis (Houndmills, Basingstoke, England) · 2021Article
- Multiple Sclerosis Patient Management During the COVID-19 Pandemic: Practical Recommendations From the Portuguese Multiple Sclerosis Study Group (GEEM).Frontiers in neurology · 2021Article
- A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination.Frontiers in neurology · 2021Article
- Response of the multiple sclerosis community to COVID-19.Multiple sclerosis (Houndmills, Basingstoke, England) · 2020Article
- Multiple sclerosis management during the COVID-19 pandemic.Multiple sclerosis (Houndmills, Basingstoke, England) · 2020Article
- Research interrupted: The impact of the COVID-19 pandemic on multiple sclerosis research in the field of rehabilitation and quality of life.Multiple sclerosis journal - experimental, translational and clinicalArticle
- A Qualitative, Multiperspective Inquiry of Multiple Sclerosis Telemedicine in the United States.International journal of MS careArticle
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
32552382What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.